Tolazamide (Mylan Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the Tolazamide drug offered from Mylan Pharmaceuticals Inc.. This Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Mylan Pharmaceuticals Inc.
NON-PROPRIETARY NAME: tolazamide
SUBSTANCE NAME: TOLAZAMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2013-01-18
END MARKETING DATE: 0000-00-00


Tolazamide HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTolazamide from Mylan Pharmaceuticals Inc.
LABELER NAME: Mylan Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 250(mg/1)
START MARKETING DATE: 2013-01-18
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0378-0217_e55c3303-e629-490e-b2f7-650b99099e74
PRODUCT NDC: 0378-0217
APPLICATION NUMBER: ANDA070259

Other TOLAZAMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Mylan Pharmaceuticals Inc.Tolazamide
PD-Rx Pharmaceuticals, Inc.Tolazamide